ENTITY
Hugel Inc

Hugel Inc (145020 KS)

50
Analysis
Health CareSouth Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
05 Oct 2017 22:59

Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?

Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...

Logo
1.1k Views
Share
bullishHugel Inc
10 Aug 2017 13:21

Hugel: Botulinum Injects Sales from Exports

Strong sales momentum, low price volatility versus the Korean market,and improving asset turnover relative to its sector In April, Hugel signed a...

Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
01 Aug 2016 15:19

Alpha Generation & Share Buybacks in Korea

Korean companies are showing increasing willingness to buyback shares. Korea Stock Exchange announced that from beginning of this year to as of 27...

Logo
591 Views
Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.5k Views
Share
x